Survey: Consumers aren’t fond of the pharma industry

The reputation of the pharmaceutical industry is tanking among U.S. consumers, the latest Gallup poll reveals.

The poll, which ranked Americas’ views of U.S. business industry sectors, placed the pharma industry at the bottom with a net-positive score of -31. Industries with the top views included restaurant (+58), computer (+50) and grocery (+43).

“Americans are more than twice as likely to rate the pharmaceutical industry negatively (58%) as positively (27%),” the poll reads.

The pharma industry unseated the federal government as the lowest-rates industry––the government placed or tied for last consistently from 2011 to 2018. In fact, “few industries have been rated lower than the pharmaceutical industry's current -31 net rating,” the poll noted.

The low image comes as the pharma industry is at the center of the national opioid abuse and overdose epidemic, which claimed 68,000 lives last year. At the same time, drug prices have skyrocketed over the past several years with few signs of slowing down, leaving patients on the financial hook.

Thousands of lawsuits have been launched against some of the biggest producers of opioids, including Purdue Pharma, which is currently negotiating a settlement rumored to fetch between $10 billion and $12 billion, and Johnson & Johnson, which faces a $572 million judgment.

“As the opioid epidemic rages on––and as the actors involved in creating it continue to experience lawsuits, protests and public shaming––it may be hard for the pharmaceutical industry to make a comeback just yet,” the Gallup poll report reads. “The industry's rating likely will not recover until its role in the opioid epidemic is addressed, and the political pressure on the industry for high prices and massive profits subsides.”

Other industries could see their favorability turn if economic forces change, the report concluded.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”